STAMFORD, Conn.--(BUSINESS WIRE)--March 16, 2005--
Archstone Consulting, a firm focused on delivering independent, strategic advice and operational results, today announced that it has expanded its Medicare Strategic Services designed to help pharmaceutical companies prepare for the implications of the Medicare Modernization Act (MMA). Archstone Consulting has implemented a suite of Medicare services that have evolved from Medicare education and contracting strategy development, to helping pharmaceutical companies assess the MMA's implications on sales, brand and marketing strategies.
The MMA has presented the pharmaceutical industry with unique challenges. Despite the magnitude of the challenges, companies are faced with a limited window of opportunity to adequately prepare for the new market changes. As the new stakeholders, including elderly beneficiaries and payors with new business models, begin to shape their role and position in the new MMA market, pharmaceutical companies are being forced to realign their current strategies and processes to accommodate new business requirements.
